Stomach Ulcer clinical trials
The registry lists 116 studies for Stomach Ulcer across more than 10 countries. 13 are recruiting or about to start. 76 of them are mainly about Stomach Ulcer (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-02.
Get an email when these change. Save the Stomach Ulcer studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
AstraZeneca (17) · Takeda (14) · POZEN (8) · Eisai Co., Ltd. (5) · Hamamatsu University (4) · Nanfang Hospital, Southern Medical University (3) · RenJi Hospital (3) · DiaSorin Inc. (2)
What is being tested here
Drugs under test in Stomach Ulcer studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Vonoprazan | 1 | 8 | 10 |
| Ciprofol | 1 | 0 | 2 |
| Aspirin | 1 | 1 | 2 |
| Fexuprazan | 1 | 1 | 1 |
| Sucralfate | 1 | 0 | 1 |
| Esomeprazole | 0 | 9 | 11 |
| Lansoprazole | 0 | 5 | 7 |
| Rebamipide | 0 | 1 | 4 |
| Amoxicillin | 0 | 2 | 4 |
| Rabeprazole | 0 | 3 | 4 |
Drug classes tested here NSAIDs 1 open · Proton pump inhibitors (PPIs) 23
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Dec 2026Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing · LanZhou University
- Jul 2027The Use of Indocyanine Green to Visualize Blood Flow to the Gastrojejunostomy During Bariatric Surgery. · University Health Network, Toronto
Who these studies take
Of the 10 Stomach Ulcer studies recruiting now, 6 (60%) set no upper age limit and 3 (30%) stop at 75 or younger. 1 (10%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (20%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (10%) | 1 (10%) |
| 18 | 8 (80%) | 8 (80%) |
| 30 | 9 (90%) | 9 (90%) |
| 40 | 9 (90%) | 9 (90%) |
| 50 | 10 (100%) | 10 (100%) |
| 65 | 9 (90%) | 9 (90%) |
| 75 | 7 (70%) | 7 (70%) |
| 85 | 6 (60%) | 6 (60%) |
Across all 116 studies, recruiting or not: 28% stop at 75 or younger and 16% at 65; 12% take children; 0% are for women only and 3% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Stomach Ulcer studies take
Of 15 observational studies under Stomach Ulcer, half reached primary completion within 40 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Observational | 40 mo25–81 · 15 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting1
Studies
Recruiting first, then most recently updated. Showing 50 of 116. Browse all 116 → or search them.
- Efficacy and Safety of Vonorasan Versus Esomeprazole in the Treatment of Ulcers After Endoscopic Submucosal DissectionRecruitingNCT06526455Phase 41 country
- Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric UlcerNot yet recruitingNCT07730138Phase 32 countries
- Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic TreatmentRecruitingNCT06543316Not applicable1 country
- The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric BypassRecruitingNCT05320796Phase 41 country
- Esomeprazole Plus Sucralfate for Post-ESD Ulcer HealingNot yet recruitingNCT07312370Phase 41 country
- Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'RecruitingNCT07385235Phase 11 country
- Endoscopic Metabolic and Bariatric TherapiesEnrolling by invitationNCT057259671 country
- A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies ScreeningRecruitingNCT070329611 country
- Functional Changes in the Stomach and Esophagus After One Anastomosis Gastric Bypass- OAGBRecruitingNCT04422405Not applicable1 country
- Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early DiagnosisRecruitingNCT068224131 country
- Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic DiseaseRecruitingNCT06541691Not applicable1 country
- Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients.RecruitingNCT05517408Not applicable1 country
- Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant DiseaseRecruitingNCT039729561 country
- Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home ScenariosCompletedNCT06848400Not applicable3 countries
- Functional Food ProductCompletedNCT07789561Not applicable1 country
- A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal UlcerCompletedNCT03553563Phase 31 country
- The Use of Indocyanine Green to Visualize Blood Flow to the Gastrojejunostomy During Bariatric Surgery.Active, not recruitingNCT06002906Phase 41 country
- The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'CompletedNCT06902818Phase 11 country
- Ulcer Pomegranate MuffinsCompletedNCT07123259Not applicable1 country
- A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients with Gastric UlcerCompletedNCT05656092Phase 31 country
- Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects.CompletedNCT06642987Phase 11 country
- Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric UlcerCompletedNCT05448001Phase 31 country
- Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity PatientsCompletedNCT05518929Phase 41 country
- Understanding Ayurveda Disease Conditions and Treatment ResponsesCompletedNCT061672261 country
- Systems Biology of Gastrointestinal and Related DiseasesTerminatedNCT055794441 country
- MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients)CompletedNCT04724291Not applicable1 country
- A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal UlcerCompletedNCT052082681 country
- HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese PatientsStatus unknownNCT05526339Not applicable1 country
- Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes SurveysCompletedNCT020320301 country
- Helicobacter Pylori Sample Collection Protocol Pre Therapy SubjectsCompletedNCT030607462 countries
- Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori InfectionCompletedNCT03050307Phase 34 countries
- Post-marketing Clinical Study of Rebamipide in Patients With Gastric UlcerCompletedNCT00233389Phase 41 country
- Compare the Effect of Eupatilin and Rebamipide on the Prevention of GastroenteropathyStatus unknownNCT04885751Phase 4
- Evaluation of Biliary Reflux After Mini-gastric Bypass With Using the Biliary Reflux IndexStatus unknownNCT04845438Not applicable1 country
- Helicobacter Pylori Eradication With a New Sequential TreatmentCompletedNCT00132171Phase 31 country
- Effect of Chicken Egg Antibody (IgY) on Patients With Chronic GastritisCompletedNCT02721355Not applicable1 country
- Comparison Between Two Types of Sedation for Elective Upper Endoscopy ProceduresCompletedNCT04410211Not applicable1 country
- Diagnosis of Gastric Lesions From Exhaled Breath and SalivaCompletedNCT014205882 countries
- Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"CompletedNCT032149521 country
- Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple TherapyCompletedNCT03609892Phase 41 country
- Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric UlcerCompletedNCT02761512Phase 31 country
- Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience InvestigationCompletedNCT015626001 country
- Nexium Capsules LDA Specific Clinical Experience InvestigationCompletedNCT017291821 country
- A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNAStatus unknownNCT030571711 country
- Helicobacter Pylori Sample Collection Protocol Post Therapy SubjectsCompletedNCT030607332 countries
- A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole SodiumCompletedNCT00125736Phase 41 country
- Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose AspirinCompletedNCT024231871 country
- To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy SubjectsCompletedNCT03291418Phase 1/21 country
- Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet AgentsTerminatedNCT02840929Not applicable2 countries
- Effect of Selective COX-2 Inhibition on Ulcer HealingCompletedNCT00153673Phase 31 country